Abstract
To obtain a candidate tumor-imaging agent, Silodosin was labeled with technetium-99m. The 95% radiochemical yield was reached under the following conditions: 100 µg of Silodosin, 100 µg of SnCl2·2H2O, 100 µL of buffer solution (pH 4), 80°C, 15 min. The biodistribution of 99mTc-Silodosin in normal and tumored mice revealed the potential for using the tracer to diagnose the solid tumor. The tumored/nontumored muscle ratio was 3.33 at 60 min post-injection, indicating high affinity of 99mTc-Silodosin for the solid tumor. The in vitro uptake of the tracer by PC-3 cells revealed the ability of 99mTc-Silodosin to conjugate with the adrenoceptor found in the prostate.
Similar content being viewed by others
REFERENCES
Lei, Chen, Jing, Yang, Tao, Huang, Xiangyin, Kong, Lin, Lu, and Yu-Dong, Cai, J. Biomol. Struct. Dyn., 2016, vol. 34, no. 3, pp. 664–675. https://doi.org/10.1080/07391102.2015.1042915
Hanahan, D. and Weinberg, R.A., Cell, 2000, vol. 100, no. 1, pp. 57–70. https://doi.org/10.1016/s0092-8674(00)81683-9
Castillejos-Molina, R.A. and Gabilondo-Navarro, F.B., Salud Publica Mex., 2016, vol. 58, no. 2, pp. 279–284. https://doi.org/10.21149/spm.v58i2.7797
Jung, J.H., MacDonald, R., Kim, J., Kim, M.H., and Dahm, P., Cochrane Database Syst. Rev., 2017, vol. 11, no. 11, ID CD012615. https://doi.org/10.1002/14651858.CD012615.pub2
Sato, Y., Otani, T., Amano, T., Araki, T., Kondou, N., Matsukawa, M., Tobe, M., Haga, K., Uchida, K., and Honma, I., Int. J Urol., 2017, vol. 24, no. 8, pp. 626–631. https://doi.org/10.1111/iju.13392
Villa, L, Capogrosso, P., Capitanio, U., Martini, A., Briganti, A., Salonia, A., and Montorsi, F., Adv. Ther., 2019, vol. 36, no. 1, pp. 1–18. https://doi.org/10.1007/s12325-018-0854-2
Kawahara, T., Aljarah, A.K., Shareef, H.K., Inoue, S., Ide, H., Patterson, J.G., Kashiwagi, E., Han, B., Li, Y., Zheng, Y., and Miyamoto, H., Prostate, 2016, vol. 76, pp. 744–756.
Mello-Andrade, F., da Costa, W.L., Pires, W.C., de Castro Pereira, F., Cardoso, C.G., de Souza Lino, R. Jr., Irusta, V.R.C., Carneiro, C.C., de Melo-Reis, P.R., Castro, C.H., Almeida, M.A.P., Batista, A.A., and de Paula Silveira-Lacerda, E., Tumor Biology, 2017, vol. 39, no. 10. https://doi.org/10.1177/1010428317695933
Ozaslan, M., Karagoz, I.D., Kilic, I.H., and Guldur, M.E., Afr. J. Biotechnol., 2011, vol. 10, pp. 2375–2378.
Calixto-Campos, C., Zarpelon, A.C., Correa, M., Cardoso, R.D.R., Ribeiro, F.P., Cecchini, R., Moreira, E.S., Crespigio, J., Bernardy, C.C.F., Casagrande, R., and Verri, W.A., Jr., BioMed. Res. Int., 2013, ID 624815. https://doi.org/10.1155/2013/624815
Pallapolu, K., Validated Estimation of Silodosin in Pure Pharmaceuticals and in Bsample by UV Spectroscopy and RP-HPLC Method, Master Thesis, 2012.
Khater, S.I., El-Sharawy, D.M., El Refaye, M.S., and Farrag, N.S., J. Radioanal. Nucl. Chem., 2020, vol. 325, pp. 343–355.
DeGoeij, M.M.K. and Sluyser, M., Eur. J. Cancer, 1996, vol. 32, pp. 1603–1608.
Jageti, G.C. and Rao, S.K., Biol. Pharm. Bull., 2006, vol. 29, pp. 460–466.
Kittel, B., Ruehl-Fehlert, C., Morawietz, G., Klapwijk, J., Elwell, M.R., Lenz, B., O’Sullivan, M.G., Roth, D.R., and Wadsworth, P.F., Exp. Toxicol. Pathol., 2004, vol. 55, pp. 413–431.
El-Kolaly, M.T., Abd-Mohty, A., and Talaat, H., in Sixth Arab Conf. on the Peaceful Uses of Atomic Energy, Cairo (Egypt), 2002.
Rashed, H.M., Marzook, F.A., and Farag, H., Radiol. Med., 2016, vol. 121, pp. 935–943. https://doi.org/10.1007/s11547-016-0677-7
Huang, R., Zhao, Z, Ma, X., Li, S., Gong, R., and Kuang, A., Cancer Gene Ther., 2011, vol. 18, pp. 144–152. https://doi.org/10.1038/cgt.2010.66
Montosori, F., Eur. Urol. Suppl., 2010, vol. 9, no. 4, pp. 491–495. https://doi.org/10.1016/j.eursup.2010.04.001
Matsubara, Y., Kanazawa, T., Kojima, Y., Abe, Y., Kobayashi, K., Kanbe, H., Harada, H., Momose, Y., Terakado, S., Adachi, Y., and Midgley, I., Yakugaku Zasshi, 2006, vol. 237–245. https://doi.org/10.1248/yakushi.kj00004483559
Rossi, M. and Roumeguère, T., Drug Des. Devel. Ther., 2010, vol. 4, pp. 291–297. https://doi.org/10.2147/DDDT.S10428
Hodeeb, Y.M.I., Hasan, M.S.M., and Abdelhafez, M.A.B., Egypt. J. Hospital Med., 2019, vol. 77, no. 4, pp. 5482–5487. https://doi.org/10.12816/EJHM.2019.60256
Yamamoto, T., Nozaki-Taguchi, N., and Sakashita, Y., Brain Res, 2001, vol. 909, p. 138. https://doi.org/10.1016/s0006-8993(01)02650-6
Harrold, K., Gould, D., and Drey, N., Eur. J. Cancer Care, 2013, vol. 22, no. 2, pp. 169–178. https://doi.org/10.1111/ecc.12023
Roehrborn, C.G., Cruz, F., Fusco, F., Adv. Ther., 2016, vol. 33, no. 12, pp. 2110–2121. https://doi.org/10.1007/s12325-016-0423-5
Shibata, K., Foglar, R., Horie, K., et al., Mol. Pharmacol., 1995, vol. 48, pp. 250–258.
Tatemichi, S., Kobayashi, K., Maezawa, A., et al., Yakugaku Zasshi, 2006, vol. 126, pp. 209–216.
ACKNOWLEDGMENTS
The authors are grateful to Assistant Prof. Ahmed Rashad for his valuable help and support in completing this paper.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Refaye, M.S.E., Khater, S.I., Essam, H.M. et al. Radiosynthesis, In Vitro and In Vivo Evaluation of 99mTc-Silodosin as a Tumor Marker in Mice. Radiochemistry 63, 828–834 (2021). https://doi.org/10.1134/S1066362221060151
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1066362221060151